These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8942749)

  • 21. Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association.
    Park S; Ahn S; Hong M; Ko YH
    Hum Pathol; 2017 Jan; 59():113-119. PubMed ID: 27697589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.
    Kuo SH; Cheng AL
    Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.
    Lai YC; Wang TH; Huang SH; Yang SS; Wu CH; Chen TK; Lee CL
    World J Gastroenterol; 2003 Jul; 9(7):1537-40. PubMed ID: 12854158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
    Cammarota G; Tursi A; Cannizzaro O; Papa A; Cuoco L; Cianci R; Fedeli P; Fedeli G; Gasbarrini G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):361-4. PubMed ID: 9476192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
    Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective long-term endoscopic and histologic follow-up of gastric lymphoproliferative disease of early stage IE low-grade B-cell mucosa-associated lymphoid tissue type following Helicobacter pylori eradication treatment.
    Weston AP; Banerjee SK; Horvat RT; Zoubine MN; Campbell DR; Cherian R
    Int J Oncol; 1999 Nov; 15(5):899-907. PubMed ID: 10536171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication.
    Iwai H; Nakamichi N; Nakae K; Konishi M; Inaba M; Hoshino S; Baba S; Amakawa R
    Laryngoscope; 2009 Aug; 119(8):1491-4. PubMed ID: 19504556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microsatellite instability at D18S61 is associated with no regression of gastric mucosa-associated lymphoid tissue lymphoma after Helicobacter pylori eradication.
    Hiyama T; Haruma K; Kitadai Y; Ito M; Masuda H; Miyamoto M; Tanaka S; Yoshihara M; Sumii K; Shimamoto F; Chayama K
    Oncol Rep; 2001; 8(2):293-7. PubMed ID: 11182043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment.
    Ono S; Kato M; Ono Y; Itoh T; Kubota K; Nakagawa M; Shimizu Y; Asaka M
    Gastrointest Endosc; 2008 Oct; 68(4):624-31. PubMed ID: 18534580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori.
    Takimoto T; Kimura K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Ido K
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S63-6. PubMed ID: 8574739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression of EI2-stage low-grade gastric MALT-lymphoma after H. pylori eradication.
    Cammarota G; Fedeli P; Bianchi A; Cianci R; Martino A; Fedeli G; Gasbarrini G
    Hepatogastroenterology; 2005; 52(63):975-7. PubMed ID: 15966244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
    Nakamura T; Nakamura S; Yonezumi M; Suzuki T; Matsuura A; Yatabe Y; Yokoi T; Ohashi K; Seto M
    Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regression of CD5-positive and Helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma of the rectum after administration of antibiotics: report of a case.
    Hisabe T; Imamura K; Furukawa K; Tsuda S; Matsui T; Yao T; Kanda M; Ohshima K; Kikuchi M
    Dis Colon Rectum; 2002 Sep; 45(9):1267-70. PubMed ID: 12352248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication.
    Montalban C; Santon A; Boixeda D; Bellas C
    Gut; 2001 Oct; 49(4):584-7. PubMed ID: 11559658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
    J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
    Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.
    Wündisch T; Thiede C; Morgner A; Dempfle A; Günther A; Liu H; Ye H; Du MQ; Kim TD; Bayerdörffer E; Stolte M; Neubauer A
    J Clin Oncol; 2005 Nov; 23(31):8018-24. PubMed ID: 16204012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group.
    Sackmann M; Morgner A; Rudolph B; Neubauer A; Thiede C; Schulz H; Kraemer W; Boersch G; Rohde P; Seifert E; Stolte M; Bayerdoerffer E
    Gastroenterology; 1997 Oct; 113(4):1087-90. PubMed ID: 9322502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
    Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.